Epilepsy Treatment

Alkem Laboratories Launches NeuCeno for Epilepsy; Targets 9.4 Million Patients in India

Alkem Laboratories launches NeuCeno (cenobamate) for partial-onset seizures in India, targeting 9.4 million patients with a once-daily anti-seizure medication.

Alkem Laboratories · 16 Sep 2026, 11:43 AM IST